Hypoxia-inducible factor-1α and semaphorin4d genes involved with tumor-associated macrophage-induced metastatic behavior and clinical significance in colon cancer

Chinese Medical Journal

Volumn 127, Issue 20, 2014, Pages 3568-3575

  Mu, Lin Jun ^a   Wang, Jin Shen ^a   Chen, Yue Zhi ^a   Ping, Li Le ^a   Bo, Guo Xiao ^a   Sheng, Zheng ^a   Jing, Chang Qing ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Colon cancer; Hypoxia inducible factor 1 alpha; Metastasis; Semaphorin4d; Tumor associated macrophages

Indexed keywords

ARGINASE 1; CD 206; CELL SURFACE MARKER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG; CD100 ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ANGIOGENESIS ASSAY; ARTICLE; BRIGHT FIELD MICROSCOPY; CANCER CELL; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELLULAR SECRETION; COCULTURE; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEALING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; COLON TUMOR; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; ANTIGENS, CD; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SEMAPHORINS;

EID: 84907981501     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20141114     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Jemal A, Bray F, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, et al. Targeting gene expression to hypoxic tumor cells. Nat Med 1997; 3: 515-520.
4. Bracken CP, Whitelaw ML, Peet DJ. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 2003; 60: 1376-1393.
5. Metzen E, Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing. J Biol Chem 2004; 385: 223-230.
6. Hellwig-Bürgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1β and tumor necrosis factor stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999; 94: 1561- 1567.
7. Blouin CC, Pagé EL, Soucy GM, Richard DE. Hypoxic gene activation by lipopolysaccharide in macrophages: implication ofhypoxia-inducible factor 1α. Blood 2004; 103: 1124-1130.
8. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002; 109: 777.
9. Folkman J. What is the evidence that tumors are angiogenesis dependent? Natl Cancer Inst 1990; 82: 4-6.
10. Sun Q, Zhou H, Binmadi NO, Basile JR. Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J Biol Chem 2009; 284: 32066-32074.
11. Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A 1996; 93: 11780-11785.
12. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T, et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 2000; 13: 633-642.
13. Basile JR, Castilho RM, Williams VP, Gutkind JS. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A 2006; 103: 9017-9022.
14. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005; 105: 4321-4329.
15. Basile JR, Holmbeck K, Bugge TH, Gutkind JS. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 2007; 282: 6899-6905.
16. Sierra JR, Corso S, Caione L, Conrotto P, Cignetti A, Piacibello W, et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med 2008; 205: 1673-1685.
17. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006; 42: 717-727.
18. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66: 605-612.
19. Yue ZQ, Liu YP, Ruan JS, Zhou L, Lu Y. Tumor-associated macrophages: a novel potential target for cancer treatment. Chin Med J 2012; 125: 3305-3311.
20. Tanigawa N, Amaya H, Matsumura M, Lu C, Kitaoka A, Matsuyama K, et al. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 1997; 57: 1043-1046.
21. Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal cancer with special reference to mode of metastasis and recurrence. Oncology 1998; 55: 575-581.
22. McCarty MF, Barroso-Aranda J, Contreras F. Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy. Med Hypotheses 2010; 74: 789-797.
23. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, et al. Regulation of colon cancer cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63: 1138-1143.
24. Kaidi A, Qualtrough D, Williams AC, Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 2006; 66: 6683-6691.
25. Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F, et al. Hypoxia-inducible factor-1α promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 2006; 66: 1684-1693.
26. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, et al. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res 2000; 60: 4010-4015.
27. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 2000; 59: 47-53.
28. Schmitz KJ, Müller CI, Reis H, Alakus H, Winde G, Baba HA, et al. Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal cancer. Int J Colorectal Dis 2009; 24: 1287-1296.
29. Rajaganeshan R, Prasad R, Guillou PJ, Scott N, Poston G, Jayne DG. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases. Eur J Surg Oncol 2009; 35: 1286-1294.
30. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, et al. Expression of hypoxia inducible factor 1α is associated with tumor vascularization in human colorectal cancer. Int J Cancer 2003; 105: 176-181.
31. Furlan D, Sahnane N, Carnevali I, Cerutti R, Bertoni F, Kwee I, et al. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal cancers. Hum Pathol 2008; 39: 1483-1494.
32. Kreuter M, Bielenberg D, Hida Y, Hida K, Klagsbrun M. Role of neuropilins and semaphorins in angiogenesis and cancer. Ann Hematol 2002; 81: S74.
33. Granziero L, Circosta P, Scielzo C, Frisaldi E, Stella S, Geuna M, et al. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood 2003; 101: 1962-1969.
34. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303-7311.
35. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005; 142: 481-489.
36. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immuno 2002; 23: 549-555.
37. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease. Cancer 2001; 91: 854-862.
38. Mariani F, Sena P, Marzona L, Riccio M, Fano R, Manni, et al. Cyclooxygenase-2 and hypoxia-inducible factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett 2009; 279: 221-229.
39. Haddad JJ, Harb HL. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. Int Immunopharmacol 2005; 5: 461- 483.
40. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.